Vitamin A prevents the irreversible proliferation of vaginal epithelium induced by neonatal injection of keratinocyte growth factor in mice
- PMID: 12596044
- DOI: 10.1007/s00441-002-0667-z
Vitamin A prevents the irreversible proliferation of vaginal epithelium induced by neonatal injection of keratinocyte growth factor in mice
Abstract
Exposure of female mice to estrogen during the perinatal period results in estrogen-independent persistent proliferation and cornification of the vaginal epithelium when the animals become adults. However, the occurrence of such irreversible vaginal changes is blocked by concurrent vitamin A treatment. Neonatal exposure to keratinocyte growth factor (KGF), which is a paracrine mediator of epithelial-mesenchymal interactions, also induces the persistent proliferation and cornification of the vaginal epithelium in adult mice. This study was designed to examine whether concurrent administration of vitamin A inhibits the development of the irreversible vaginal changes in mice exposed neonatally to KGF. The vaginal epithelium in ovariectomized 35-day-old mice given 5 microg of KGF for 3 days after birth possessed a significantly larger number of layers and increased thickness as compared to that in control mice. Concurrent injections of 100 IU of vitamin A acetate inhibited the occurrence of the irreversible proliferation of the vaginal epithelium. These changes were equal to the results observed when 20 micro g of estrogen with or without vitamin A acetate was administered for 5 days after birth. Unlike the case of estrogen treatment, the effect of neonatal treatment with KGF seemed to appear after a latent period, since the vaginal epithelium did not show proliferation soon after the treatment. We discuss the inhibitory effect of VA on the irreversible vaginal changes induced by neonatal KGF treatment with reference to endocrine disruption by neonatal estrogen exposure.
Similar articles
-
Prevention of neonatal estrogen imprinting by vitamin A as indicated by estrogen receptor expression in the mouse vagina.Cell Tissue Res. 2001 Dec;306(3):441-7. doi: 10.1007/s004410100459. Epub 2001 Oct 23. Cell Tissue Res. 2001. PMID: 11735045
-
Involvement of keratinocyte growth factor (KGF)-KGF receptor signaling in developmental estrogenization syndrome of mouse vagina.Cell Tissue Res. 2004 Dec;318(3):591-8. doi: 10.1007/s00441-004-0980-9. Epub 2004 Oct 5. Cell Tissue Res. 2004. PMID: 15480797
-
Prevention by vitamin A of the occurrence of permanent vaginal and uterine changes in ovariectomized adult mice treated neonatally with diethylstibestrol and its nullification in the presence of ovaries.Exp Clin Endocrinol. 1985 Apr;85(2):129-37. doi: 10.1055/s-0029-1210428. Exp Clin Endocrinol. 1985. PMID: 4018158
-
Developmental mechanism of estrogen-induced irreversible changes in the mouse cervicovaginal epithelium.Natl Cancer Inst Monogr. 1979 May;(51):41-56. Natl Cancer Inst Monogr. 1979. PMID: 384264 Review.
-
Keratinocyte growth factor/fibroblast growth factor 7, a homeostatic factor with therapeutic potential for epithelial protection and repair.Adv Cancer Res. 2004;91:69-136. doi: 10.1016/S0065-230X(04)91003-2. Adv Cancer Res. 2004. PMID: 15327889 Review.
Cited by
-
Activated vitamin D3 and pro-activated vitamin D3 attenuate induction of permanent changes caused by neonatal estrogen exposure in the mouse vagina.J Reprod Dev. 2014;60(4):274-9. doi: 10.1262/jrd.2014-015. Epub 2014 Apr 25. J Reprod Dev. 2014. PMID: 24769840 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical